scispace - formally typeset
M

Michael Detmar

Researcher at École Polytechnique Fédérale de Lausanne

Publications -  351
Citations -  43193

Michael Detmar is an academic researcher from École Polytechnique Fédérale de Lausanne. The author has contributed to research in topics: Lymphatic system & Lymphangiogenesis. The author has an hindex of 94, co-authored 334 publications receiving 39086 citations. Previous affiliations of Michael Detmar include Harvard University & Beth Israel Deaconess Medical Center.

Papers
More filters
Journal ArticleDOI

Ocular versus extraocular neovascularization: Mirror images or vague resemblances

TL;DR: The First ARVO/Pfizer Ophthalmics Institute meeting was held Friday and Saturday, April 29 and 30, 2005, in Fort Lauderdale, Florida, in conjunction with the 2005 ARVO Annual Meeting.
Journal ArticleDOI

Identification of the surface-accessible, lineage-specific vascular proteome by two-dimensional peptide mapping

TL;DR: The results identify the surface‐accessible, vascular lineage‐specific proteome, and they also reveal 2D‐PM as a powerful technology for the large‐scale screening of lineage‐ specific protein expression.
Journal ArticleDOI

Effect of Recombinant Tumor Necrosis Factor-Alpha on Cultured Microvascular Endothelial Cells Derived From Human Dermis

TL;DR: A major role of TNF is suggested in the mediation of leucocyte adhesion to endothelial cells of the skin microvasculature with possible implications for the initiation and maintenance of inflammatory skin processes.
Journal ArticleDOI

A rapid fluorometric assay for the determination of keratinocyte proliferation in vitro

TL;DR: The fluorometric assay is a simple, fast and reliable method to assess cell number in keratinocyte cultures and reliably detected the growth inhibitory effect of recombinant interferon gamma on human keratinocytes.
Journal ArticleDOI

Expansion of the lymphatic vasculature in cancer and inflammation: new opportunities for in vivo imaging and drug delivery.

TL;DR: A new method, using antibodies to a lymphatic specific marker and positron emission tomography, to sensitively detect lymphatic expansion in lymph nodes as the earliest sign of cancer metastasis is developed.